Clinical practice. Giant-cell arteritis and polymyalgia rheumatica - Wikidata - awgldk - TriplyDB

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

http://www.wikidata.org/entity/Q27005821

about

Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis Macrophages in vascular inflammation--From atherosclerosis to vasculitis [Diagnostics and treatment of polymyalgia rheumatica].Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.T cell-macrophage interactions and granuloma formation in vasculitis.Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis.Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions Identifying genetically driven clinical phenotypes using linear mixed models NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs.Giant Cell Arteritis: From Pathogenesis to Therapeutic Management.Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study A Retrospective Study of Chinese Patients With Giant Cell Arteritis (GCA): Clinical Features and Factors Associated With Severe Ischemic Manifestations Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study.Giant cell arteritis and polymyalgia rheumatica: an update.Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.Polymyalgia rheumatica: strategies for efficient practice and quality assurance.Giant Cell Arteritis of the Female Genital Tract With Occult Temporal Arteritis and Marginal Zone Lymphoma Harboring Novel 20q Deletion: A Case Report and Literature Review.Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis.Immune checkpoint dysfunction in large and medium vessel vasculitis.F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection.Microvascular Non-Arteritic Ocular Motor Nerve Palsies-What We Know and How Should We Treat?Giant Cell Arteritis - Beyond temporal artery biopsy and steroids.Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis.The prognostic value of baseline (18)F-FDG PET/CT in steroid-naïve large-vessel vasculitis: introduction of volume-based parameters.Head and neck giant cell arteritis: an autoimmune disease with many faces.A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis.Optic Nerve.Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients.Bilateral vertebral artery occlusion without headache in giant cell arteritis.Evaluation of damage in giant cell arteritis.Identification of Herpes Zoster-Associated Temporal Arteritis Among Cases of Giant Cell Arteritis.[18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic.Increased expression of interleukin-22 in patients with giant cell arteritis.A case of Horton's disease (with its potential neurological symptoms) depicted in a portrait by Andrea Mantegna.The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway.Refractory Giant Cell Arteritis Complicated by Vision Loss From Optic Atrophy and Maculopathy Associated With Pachymeningitis.Stroke as an atypical initial presentation of giant cell arteritis.A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.High-Resolution Magnetic Resonance Imaging of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Cohort Study.

P2860

Q26749091-9B80444D-AEF5-4C67-A0AF-23F8F42F8195 Q26825052-EA3AC7BC-9291-4EB2-88B8-83941F7EB41A Q30248636-C7817304-A59A-4824-9B60-88E296A47B45 Q33879740-11AC6A9C-9FB1-4F70-9BF7-065DA0F69597 Q34171890-D982E469-182A-42CC-8975-B6CE37411A39 Q36138118-61FD9060-E304-46AF-AE60-8E795859ADE2 Q36746012-667703A6-DFCA-496D-A188-0390E1C1F2CE Q36845877-2CDA3C01-0FDE-4127-AF91-43BE3A5B8FE4 Q36867379-46E04F31-0F94-42F8-82A8-380ACA6E831D Q36992669-1E814E3A-4284-42F0-BE79-7274942C4D11 Q36993376-D61560AD-0CD0-4826-9442-5460DFA78889 Q37205901-55B09F20-4EEF-4149-B079-0A550365303E Q37605575-A463B017-F246-4420-8A13-45A76E916C0F Q38331238-1839F002-1E22-4E93-807E-D500AD3C5987 Q38400787-62A611F2-737E-4E9B-A65D-6EEFE2549E8F Q38511598-BADBB9C0-EE5D-41DF-8229-67A7397B140B Q38583653-FE9A3504-623B-43FF-9775-C8B7E5B7F9E9 Q38588648-7E8DFB6B-2429-42BF-ABD9-38177B1FFEDB Q38897019-43178D2F-8BC8-4E31-A674-2135E7D98F0A Q38950827-02E4EB95-09FD-49D6-9680-1913D46E197E Q39032400-D6800EB3-0D87-40C7-94D7-C6BEC14C1A82 Q39293033-6929E05A-B5B4-481B-9F6C-5E5A5E2AC7B1 Q39356029-FC57AAF2-13DA-439C-9FF1-71DA9C61797B Q40144137-2A0DD9CA-0207-46F3-A877-5E9522542662 Q40238884-A4E2AA33-6DE0-4288-84F8-A9F376FC3F9D Q40353912-37CA90E1-55C7-4DF6-9147-7C1750381677 Q40404975-160D612D-0CF2-4E9A-85D3-48426B3B1C39 Q40481942-02A900FF-B435-492F-B595-69836B0ABDAF Q42380775-8A2BCBED-5306-41D4-9D8A-60A8672B53B9 Q42394276-07A2D021-8B68-4555-9395-67F677953247 Q46097662-65A01F1B-985B-4457-865B-AE475A6DBE7A Q47182000-B662C45D-94C9-4E95-87C6-4C88F8F6BB78 Q47617064-C2274C1D-8591-4885-8E6F-4D8ECD44BB40 Q47715350-79D05021-57A9-4B37-BC01-8F3F36695005 Q47959099-04EF27CA-A035-4C1A-9BAC-6005A78595BF Q48099660-93CAE80F-B088-498C-AD66-EFEF866CC378 Q50068609-0193D695-EC30-47B8-8AC1-750139EFF439 Q50332429-C30F0902-72F5-4E52-A8C6-60C2817F474B Q52675492-D6658097-CB3F-43D3-A362-0280BEBB4801 Q53058095-7BA9C1E4-88D6-4707-887C-DCAFC024A803

P2860

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

http://www.wikidata.org/entity/Q27005821

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

@ast

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

@en

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

@nl

type

label

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

@ast

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

@en

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

@nl

prefLabel

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

@ast

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

@en

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

@nl

P1433

Q27005821-15EFD934-5370-43AC-BCD1-FE7B556789F2

P1476

Q27005821-34542183-608C-4C4B-92D8-8BA34776962D

P2093

Q27005821-1C822613-3E80-4D08-89CF-6DD9C85C0C45

Q27005821-DCD0ECCD-91FC-46C7-98F8-B39F03B1345A

Q27005821-ED7A2A5F-1D83-41CD-B2A6-02EF53781245

P2860

Q27005821-07C0535D-CC14-42E6-8000-E5A8170A243C

Q27005821-0ED2C78E-47EA-4BA3-86D7-3E9D5821FE94

Q27005821-1362662B-E187-43F1-B23F-1F115A34E6EB

Q27005821-1398528A-3518-49CD-BCF0-080B3F2EC0C6

Q27005821-2DF2CE99-ED36-4EC4-AA83-4FA726608541

Q27005821-2F34A58B-1D02-41AC-8E60-5879C40E21F7

Q27005821-3244713A-336C-4D89-9CD9-8C06BAF74176

Q27005821-38805DDA-EDD4-4571-A434-A4353AD87007

Q27005821-3A22ED2E-EE90-42A9-B8C5-84F3DF40F7C2

Q27005821-3CB29F11-800F-43B4-AA48-0EDFA331E379

P304

Q27005821-B7689060-E548-422F-9481-AF55DD7BC948

P31

Q27005821-781AC396-2B44-42BB-B94B-EFDE16ABD537

P3181

Q27005821-789BF0BF-BB73-4BE7-BE01-C75508C3D60C

P356

Q27005821-5098240E-B570-43AA-BA7E-639B4D8A7B4C

P407

Q27005821-0DCB54F0-FA6D-4F3D-970B-25CCE62FCD40

P433

Q27005821-DA1BFAD1-8EC7-41E0-AB3F-085D4BFCEEB7

P478

Q27005821-C39CC646-1A52-4303-8FB0-E5FEA7DA8DE4

P577

Q27005821-8C3B6DF9-A870-4757-BC28-957862599EE2

P698

Q27005821-6C043584-9936-4509-B3A9-4950F5A4A2A2

P932

Q27005821-D106132F-28B9-46FF-AFAD-8408F94C6595

P3181

P356

P1433

The New England Journal of Medicine

P1476

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

@en

P2093

Caren G. Solomon

http://www.w3.org/2001/XMLSchema#string

Cornelia M. Weyand

http://www.w3.org/2001/XMLSchema#string

Jörg J. Goronzy

http://www.w3.org/2001/XMLSchema#string

P2860

The immunopathology of giant cell arteritis: diagnostic and therapeutic implications

Medium- and large-vessel vasculitis

Role of ultrasonography in the diagnosis of temporal arteritis.

Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.

Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study.

Statin use in giant cell arteritis: a retrospective study.

Th17 and Th1 T-cell responses in giant cell arteritis.

Diagnostic performance of ¹⁸F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis.

Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis

The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

P304

50-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1947463

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMCP1214825

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

371

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24988557

http://www.w3.org/2001/XMLSchema#string

P932

4277693

http://www.w3.org/2001/XMLSchema#string